Menopausal Hormone Therapy and Risk of Epithelial Ovarian Cancer.

The article discusses a study which examined the link between menopausal hormone therapy and the risk of epithelial ovarian cancer. The study participants are female residents of a 13-county area of western Washington state, 25 to 74 years old, who were diagnosed with primary invasive or borderline epithelial ovarian tumor between January 1, 2002 and December 31, 2005. It revealed that the risk was increased among current or recent users of unopposed estrogen (ET) compared to those who are long-term ET users who discontinued use in the more distant past.